ACC.24 - There is an unmet treatment need for nonobstructive hypertrophic cardiomyopathy (nHCM). Martin Maron shares the results of IMPROVE-HCM, which evaluated the efficacy and safety of the novel cardiac mitotrope ninerafaxstat in nHCM.
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
Restart
Resume
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Overview
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Martin Maron, MD is Director of the Hypertrophic Cardiomyopathy Center Lahey Medical Center and Hospital in Burglington, MA, US. He also is Board Director at the Chanin T. Mast Hypertrophic Cardiomyopathy Center in Morristown Medical Center, Morristown, NJ, VS.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of IMPROVE-HCM
Release date: 22 April 2024
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
ACC.24 - There is an unmet treatment need for nonobstructive hypertrophic cardiomyopathy (nHCM). Martin Maron shares the results of IMPROVE-HCM, which evaluated the efficacy and safety of the novel cardiac mitotrope ninerafaxstat in nHCM.
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Martin Maron, MD is Director of the Hypertrophic Cardiomyopathy Center Lahey Medical Center and Hospital in Burglington, MA, US. He also is Board Director at the Chanin T. Mast Hypertrophic Cardiomyopathy Center in Morristown Medical Center, Morristown, NJ, VS.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of IMPROVE-HCM
Release date: 22 April 2024
Presenters
Facebook Comments